On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

A meeting Wednesday at the Food and Drug Administration about fluoride supplements became, at one point, a contentious ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...